Patent case had almost nothing to do with recent drop. Monday had the huge volume and drop and the settlement conference had not even been completed. Patent is an overhang, one that will be eventually gone, odds are less than 5% of Amarin loss, stock does not sell off on a known case because of 5% chance of loss which is already built into price.
Stock is up from $17 to 21 since Adcom notes released, the raises were done at 18, time to cash in for many, ironic GS raised price now? Not ironic?
We are making a nice base in the 20's, stock is worth 25 here and 27-28 with generic suit settled, worth $30 end of next year GIA and then 2021 is when we see if management has the skills to GIA and take it much higher.
BO at min $41 in 1Q 2020 is the other option but sales related catalyst is 6 months out, market is hot, people just taking money elsewhere, stocks up 60% YTD and over 300% for 2018 which trounce the market, getting to $30 next year by end of year will trounce market again. Stocks don't just shoot up to rich valuations compared to sales overnight.
Market Data 
Markets 
AI
